Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...

For a sampling of sounds, look no further than Frequency Festival, an annual celebration of the musical avant-garde.

Explore the details of NRL's request for proposal involving a potential $244 million radio frequency R&D contract.

Frequency Therapeutics Inc (KRRO) stock has hit a 52-week low, trading at $29.8, marking a significant downturn for the company within the past year. According to InvestingPro data, the company ...

Ac-satoreotide is a first-in-class Actinium-labelled somatostatin receptor 2 antagonist targeting extensive-stage Small Cell Lung Cancer or Merkel Cell Carcinoma Orphan Drug Designation follows ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

Dr Deepti Sinha, lead consultant, Dept of ENT at the CK Birla Hospital, Delhi, said the 852 Hz frequency, part of the ...

Silence Therapeutics plc (NASDAQ:SLN), a biotechnology company specializing in RNA therapeutics, stands at a crucial juncture ...

BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

Ketamine-assisted psychotherapy (KAP) uses low doses of ketamine alongside psychotherapy to treat mental health conditions.

The latest trading session saw Viking Therapeutics, Inc. (VKTX) ending at $32.87, denoting a +0.67% adjustment from its last day's close. The stock's performance was behind the S&P 500's daily ...